Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

Kang, D; Ludwig, E; Jaworowicz, D; Huang, H; Fiedler-Kelly, J; Cortes, J; Ganguly, S; Khaled, S; Kramer, A; Levis, M; Martinelli, G; Perl, A; Russell, N; Abutarif, M; Choi, Y; Yin, O

Kang, D (corresponding author), Daiichi Sankyo Inc, Basking Ridge, NJ 07920 USA.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021; 87 (4): 513

Abstract

Purpose This analysis evaluated the relationship between concentrations of quizartinib and its active metabolite AC886 and QT interval corrected using......

Full Text Link